OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Fetal & Neonatal Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Using rising tides to lift all boats: Equity-focused quality improvement as a tool to reduce neonatal health disparities	53
Neuroimaging in the term newborn with neonatal encephalopathy	48
Neonatal encephalopathy: Focus on epidemiology and underexplored aspects of etiology	46
Neonatal encephalopathy: Etiologies other than hypoxic-ischemic encephalopathy	30
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns	29
Update on mechanisms of the pathophysiology of neonatal encephalopathy	28
Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury	26
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia	24
Need for more evidence in the prevention and management of perinatal asphyxia and neonatal encephalopathy in low and middle-income countries: A call for action	23
Unanswered questions regarding therapeutic hypothermia for neonates with neonatal encephalopathy	23
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?	21
Application and potential of artificial intelligence in neonatal medicine	20
Neurological and developmental outcomes following neonatal encephalopathy treated with therapeutic hypothermia	20
Supporting families in their child's journey with neonatal encephalopathy and therapeutic hypothermia	19
Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations	18
LISA/MIST: Complex clinical problems almost never have easy solutions	17
Placental contribution to neonatal encephalopathy	17
Management of comfort and sedation in neonates with neonatal encephalopathy treated with therapeutic hypothermia	17
A systematic review of reports of quality improvement for bronchopulmonary dysplasia	17
Respiratory support of infants born at 22–24 weeks of gestational age	16
Bedside and laboratory neuromonitoring in neonatal encephalopathy	15
Infection prevention for extremely low birth weight infants in the NICU	15
Inter-center variability in neonatal outcomes of preterm infants: A longitudinal evaluation of 298 neonatal units in 11 countries	15
Pulmonary hypertension and oxidative stress: Where is the link?	14
Diagnosis & management of pulmonary hypertension in congenital diaphragmatic hernia	14

The use of data in resource limited settings to improve quality of care	14
Proposing a care practice bundle for neonatal encephalopathy during therapeutic hypothermia	14
Nutrition and management of glycemia in neonates with neonatal encephalopathy treated with hypothermia	13
Pulmonary hypertension in the newborn- etiology and pathogenesis	13
When to say no to inhaled nitric oxide in neonates?	12
Feeding considerations for infants with craniofacial malformations	12
Pregnancy and Severe ARDS with COVID-19: Epidemiology, Diagnosis, Outcomes and Treatment	12
Evidence and practical aspects of treatment with the Tübingen palatal plate	12
Management of seizures in neonates with neonatal encephalopathy treated with hypothermia	12
National and international guidelines for neonatal caffeine use: Are they evidenced-based?	11
Cesarean delivery in low- and middle-income countries: A review of quality of care metrics and targets for improvement	11
Fluid management, electrolytes imbalance and renal management in neonates with neonatal encephalopathy treated with hypothermia	11
Maternal and neonatal outcomes following SARS-CoV-2 infection	11
Perinatal asphyxia from the obstetric standpoint	11
Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension	10
Patent ductus arteriosus management and the drift towards therapeutic nihilism – What is the evidence?	10
Delayed cord clamping in healthy term infants: More harm or good?	10
The role of bedside functional echocardiography in the assessment and management of pulmonary hypertension	10
Closing the evidence to practice gap in neonatal transfusion medicine	9
Early developmental screening and intervention for high-risk neonates - From research to clinical benefits	9
Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa	9
Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?	9
Hemodynamic support of the micropreemie: Should hydrocortisone never be left out?	9
Advantages and disadvantages of mandibular distraction in Robin sequence	9
Escaping the Finnegan – Is it time?	8
Impact of perinatal COVID on fetal and neonatal brain and neurodevelopmental outcomes	8
Tissue engineering: Relevance to neonatal congenital heart disease	8
Can we back off using antibiotics in the NICU?	8
Challenges in respiratory management during therapeutic hypothermia for neonatal encephalopathy	8
Management of cardiac dysfunction in neonates with pulmonary hypertension and the role of the ductus arteriosus	8
Harnessing mobile technology to deliver evidence-based maternal-infant care	8
Recovery of the brain after intraventricular hemorrhage	8
Cannulation and decannulation techniques for neonatal ECMO	8
Optimizing initial neonatal resuscitation to reduce neonatal encephalopathy around the world	8
Milestones for clinical translation of the artificial placenta	8
Personalized support of parents of extremely preterm infants before, during and after birth	7
Multisystem inflammatory syndrome in neonates (MIS-N) associated with perinatal SARS CoV-2 infection: Does it exist?	7
Neurodevelopmental outcomes after neonatal caffeine therapy	7
Prenatal management of congenital diaphragmatic hernia	7
Cooling in mild encephalopathy: Costs and perils of therapeutic creep	7
Towards personalized therapies for genetic disorders of surfactant dysfunction	7
Oxygen saturation (SpO2) targeting for newborn infants at delivery: Are we reaching for an impossible unknown?	7
When to start and stop caffeine and why respiratory status matters	7
General approach to delivery and resuscitation of newborn infants from mothers at risk or proven COVID-19	6
Paediatric palliative care in the NICU: A new era of integration	6
Subcutaneous fat necrosis associated with hypercalcemia in neonates with neonatal encephalopathy treated with therapeutic hypothermia	6
BPD treatments: The never-ending smorgasbord	6
Quality improvement for NICU graduates: Feasible, relevant, impactful	6
Nursing care of infants born extremely preterm	6
What is bronchopulmonary dysplasia and does caffeine prevent it?	5

Neonatal ECMO survivors: The late emergence of hidden morbidities – An unmet need for long-term follow-up	5
Genetics of craniofacial malformations	5
Translational insights into mechanisms and preventive strategies after renal injury in neonates	5
Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19	5
Expanding neonatal ECMO criteria: When is the premature neonate too premature	5
Coagulation and hemolysis complications in neonatal ECLS: Role of devices	5
The implications of routine milk fortification for the short and long-term health of preterm babies	5
The neonatal liver: Normal development and response to injury and disease	5
Caffeine exposure during pregnancy: Is it safe?	5
Surfactant status assessment and personalized therapy for surfactant deficiency or dysfunction	4
The interplay between pressure, flow, and resistance in neonatal pulmonary hypertension	4
Newborn resuscitation devices: The known unknowns and the unknown unknowns	4
Counseling for the option of termination of pregnancy for severe fetal anomalies in light of the recent Supreme Court ruling to remove the constitutional right to an abortion	4
Clinical features of neonatal COVID-19	4
The extremely preterm young adult – State of the art	4
Using continuous nasal airway pressure in infants with craniofacial malformations	4
Pivotal challenges in artificial intelligence and machine learning applications for neonatal care	4
Historical perspective on surfactant therapy: Transforming hyaline membrane disease to respiratory distress syndrome	4
Chapter for antenatal steroids – Treatment drift for a potent therapy with unknown long-term safety seminars in fetal and neonatal medicine	4
Perinatal care for the extremely preterm infant	4
Vaccination and treatment options for SARS-CoV2 infection affecting lactation and breastfeeding	4
Placental tissue stem cells and their role in neonatal diseases	4
Haematological issues in neonates with neonatal encephalopathy treated with hypothermia	4
Management of the CDH patient on ECLS	3
Targeted fortification with human milk analysis: An opportunity for innovation	3
Technology in the delivery room supporting the neonatal healthcare provider's task	3
Are we over-treating hypoxic spells in preterm infants?	3
Clinical decision support in the neonatal ICU	3
Facilitating quality improvement through routinely recorded clinical information	3
The unfinished work of neonatal very low birthweight infants quality improvement: Improving outcomes at a continental level in South America	3
Spiritual and cultural influences on end-of-life care and decision-making in NICU	3
Managing infants with craniofacial malformations – Where to go next?	3
Low blood sugar levels in the newborn infant: Do changing goal posts matter?	3
Learning with digital recording and video review of delivery room resuscitation	3
Stem cells in neonatal diseases: An overview	3
Timing of surfactant treatment in respiratory distress syndrome	3
Neonatal POCUS: Embracing our modern day “stethoscope”	3
Extracorporeal membrane oxygenation in pregnancy during the SARS-CoV-2 pandemic	3
Hemodynamic management of the micropreemie: When inotropes are not enough	3
Ethical considerations in the care of encephalopathic neonates treated with therapeutic hypothermia	3
Neurological conditions: Prognostic communication, shared decision making, and symptom management	3
Telemedicine across the continuum of neonatal-perinatal care	3
Medico-legal considerations in the context of neonatal encephalopathy and therapeutic hypothermia	3
Surfactant delivery by aerosol inhalation – past, present, and future	3
Protecting the brain of the micropreemie	3
Fetal markers for the detection of infants with craniofacial malformation	3
Persistent pulmonary hypertension of the newborn: Historical perspectives	2
Update on pre-ECMO evaluation and treatment for term infants in respiratory failure	2
Neonatal euthanasia in the context of palliative and EoL care	2
Optimizing practice guidelines through incorporating patient and family values and preferences	2
Ethics at the end of life in the newborn intensive care unit: Conversations and decisions	2
Pulmonary hypertension in pregnancy and its effects on the fetus	2
History of caffeine use in neonatal medicine and the role of the CAP trial	2
Insights into the mechanisms of alveolarization - Implications for lung regeneration and cell therapies	2
The history of neonatal intubation	2
Long term outcome of babies with pulmonary hypertension	2
From immature pharmacotherapy towards pharmacotherapy of the immature	2
The role of the nasopharyngeal prong in craniofacial disorders in particular the Pierre Robin sequence	2
Neonatal surfactant therapy beyond respiratory distress syndrome	2
Data analytics in a clinical setting: Applications to understanding breathing patterns and their relevance to neonatal disease	2
Changing populations being treated with ECMO in the neonatal period – who are the others?	2
Alternative routes of surfactant application – An update	2
Decision-making for extremely preterm infants with severe hemorrhages on head ultrasound: Science, values, and communication skills	2
Ethics of care for the micropreemies. Just because we can, should we?	2
Apnoeic oxygenation during neonatal intubation	2
Cost-effectiveness and pricing of caffeine	2
Nutrition for the micro preemie: Beyond milk	2